Abiopharma

Abivax Presents Third Quarter 2025 Financial Results

Indivior Notification

📋 BYRON C ROBINSON (Officer) plans to sell 17K shares of JANUX THERAPEUTICS, INC. (at $15.50 each, total $258K) Filed: Dec 15, 2025 | ID: 010281

New Form S-8 POS - Clearside Biomedical, Inc. Filed: 2025-12-15 AccNo: 0001193125-25-319181 Size: 30 KB

New Form POS AM - Carisma Therapeutics Inc. Filed: 2025-12-15 AccNo: 0001104659-25-121115 Size: 26 KB

New Form POS AM - Carisma Therapeutics Inc. Filed: 2025-12-15 AccNo: 0001104659-25-121116 Size: 26 KB

IO Biotech, Inc. - IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications

OmniAb - Launch of OmniUltra Expands OmniAb’sReach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

📋 SANDRA CALVIN (Officer) plans to sell 3K shares of TRAVERE THERAPEUTICS, INC. (at $36.00 each, total $105K) Filed: Dec 15, 2025 | ID: 010276

ARMEN GARO H 🟢 acquired 4.3K shares of AGENUS INC (AGEN) at $3.79 Transaction Date: Dec 12, 2025 | Filing ID: 319186

AEON Biopharma Announces Execution of Exchange Agreement with Daewoong

Launch of OmniUltra Expands OmniAb’s Reach into New Markets and Applications, Advances Leadership in Antibody Discovery Technologies

Madrigal Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference

IO Biotech Announces Publication of Five-year Clinical Outcomes of Phase 1/2 Trial in Nature Communications

📋 JOHANNA MERCIER (Officer) plans to sell 3K shares of GILEAD SCIENCES, INC. (at $122.00 each, total $366K) Filed: Dec 15, 2025 | ID: 010274